Integrating Scientific Data Management and LIMS in Biologics Drug Discovery
Explore the crucial integration of SDMS and LIMS in biologics drug discovery, enhancing data management, automation, and collaboration for scientists...
Explore the crucial integration of SDMS and LIMS in biologics drug discovery, enhancing data management, automation, and collaboration for scientists...
Automate lab data collection with a scientific data management system to increase efficiency, reduce errors, improve storage and analysis, and make...
Key considerations for adapting software systems to leverage AI and ML in biologics. Learn about data organization, scalability, metadata, processing...
Improve lab efficiency and productivity with an instrument reservation system. Learn how to implement this system using lab asset management software.
Avoid common pitfalls when implementing a laboratory information management system (LIMS) to improve productivity, accuracy, and compliance. Involve...
Learn the benefits of implementing a scientific data management system in your laboratory. Increase efficiency, enhance data security, and improve...
Learn why LIMS is crucial in biologics R&D. It improves data management, simplifies regulatory compliance, facilitates workflow, and fosters...
Discover the benefits of lab asset management software. Streamline operations, improve inventory management, track equipment usage, and ensure...
Looking back at the major developments at StackWave in 2023.
Discover the key functions and benefits of a Laboratory Information Management System (LIMS). Learn how LIMS can optimize workflows, enhance...
Clear objectives, proper planning, change management, adequate resources, and ongoing maintenance can lead to better outcomes for your LIMS...
This post explores the steps that can sometimes trap therapeutic discovery teams and CROs on the path of building their own bioregistry without...
Advances in artificial intelligence (AI) and machine learning (ML) have shown significant promise is in the de novo generation of therapeutic...
Artificial intelligence (AI) and machine learning (ML) are playing increasingly significant roles in the field of drug discovery.
It has never been more important to organize, standardize, and centralize data collection in the pursuit of new medicines.
Phage display has become an invaluable tool for the discovery of novel therapeutic agents, including nanobodies.
NGS offers an approach for identifying and extracting variable domain heavy-chain (VHH) regions from camelid B-cells.
In the fight against infectious diseases, scientists are continually seeking to outsmart pathogens. One such strategy involves the use of nanobodies.
In the search for new therapies that can treat a wide variety of neurodegenerative diseases, scientists are exploring the potential of nanobodies.
StackWave Affinity v16 Announcement - Next Generation Sequencing
An emerging therapeutic strategy to tackle cancer is nanobodies – small, single-domain antibody fragments derived from heavy-chain-only antibodies.
Nanobodies, also known as single-domain antibodies or VHHs, are small, highly stable, and specific antibody fragments.
Bulk B cell analysis is a powerful tool for antibody discovery because it provides a snapshot of the entire B cell population at a given time.
In pharmacokinetics, standard curves are used to determine the concentration of a drug in biological fluids such as blood or plasma.
ADCs are essentially a new class of drugs that combine the targeting properties of antibodies with the cell-killing ability of drugs.
Monoclonal antibodies are revolutionizing therapeutics with their precision and specificity, allowing for safer treatment of a variety of diseases...
StackWave Affinity v15 Announcement - Titration and Dose Response Experiments
The sunk cost fallacy can affect our decision making around LIMS, other software, and antibody discovery technology purchases.
StackWave Affinity™ takes a fundamentally different approach than other software solutions to the unique challenges of Antibody Discovery teams.
Every year, StackWave delivers a steady stream of improvements to our Affinity antibody discovery solution, and 2022 was no exception.
Rapid Feedback in antibody drug discovery can quickly identify issues in format, development, manufacturing, and discovery approaches and processes
Antibody sequence analysis and lead identification automation through software scripts as a means of Workflow Automation.
Fully-automated antibody lead identification example of Workflow Automation to save scientists’ time on redundant and error-prone steps.
Develop Shared Ownership to collectively empower and engage your team in accomplishing company, team, and individual goals.
We are excited to announce the release of StackWave Affinity™ v13! Highlights include integrated ELN and nanobody support.
Three principles to tame complexity in drug discovery. DrugOps emphasizes Shared Ownership, Workflow Automation, and Rapid Feedback.
We are excited to announce the release of StackWave Affinity™ v13! Highlights include custom dashboard and reporting tools and a REST API.